Crime & Law · India
Government Tightens Rules for Drug Approval Over Fake Data
The Union Health Ministry has notified stricter rules to debar drug companies that submit fake or fabricated data for regulatory approval. This action aims to prevent firms from obtaining approval through fraudulent means. The new regulations target companies attempting to bypass the standard approval process by submitting false information. The Ministry's move signifies a move towards greater accountability in the pharmaceutical sector.
How outlets across the spectrum covered it
Left 2 · Centre 11 · Right 3 n = 16
- Left (2): National Herald, The Hindu
- Centre (11 votes, 12 outlets): Amar Ujala, Business Standard, Greater Kashmir, Mint, Telangana Today, The Economic Times · The Times of India (Times Group — 1 vote), The Free Press Journal, The Hindu BusinessLine, The New Indian Express, The Statesman, The Tribune
- Right (3): Swarajya, The Pioneer, Times Now